EXE vs. DNTL, WELL, SIA, DR, KDA, NLH, PHA, BLU, TRIL, and TLRY
Should you be buying Extendicare stock or one of its competitors? The main competitors of Extendicare include dentalcorp (DNTL), WELL Health Technologies (WELL), Sienna Senior Living (SIA), Medical Facilities (DR), KDA Group (KDA), Nova Leap Health (NLH), Premier Health of America (PHA), BELLUS Health (BLU), Trillium Therapeutics (TRIL), and Tilray Brands (TLRY). These companies are all part of the "medical" sector.
dentalcorp (TSE:DNTL) and Extendicare (TSE:EXE) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, valuation, earnings, dividends, media sentiment, community ranking and profitability.
In the previous week, Extendicare had 1 more articles in the media than dentalcorp. MarketBeat recorded 1 mentions for Extendicare and 0 mentions for dentalcorp. dentalcorp's average media sentiment score of 0.30 beat Extendicare's score of 0.00 indicating that Extendicare is being referred to more favorably in the news media.
dentalcorp has a beta of 1.38, suggesting that its share price is 38% more volatile than the S&P 500. Comparatively, Extendicare has a beta of 1.23, suggesting that its share price is 23% more volatile than the S&P 500.
Extendicare has a net margin of 2.63% compared to Extendicare's net margin of -4.44%. dentalcorp's return on equity of 37.03% beat Extendicare's return on equity.
Extendicare received 125 more outperform votes than dentalcorp when rated by MarketBeat users. However, 63.41% of users gave dentalcorp an outperform vote while only 48.87% of users gave Extendicare an outperform vote.
dentalcorp presently has a consensus target price of C$10.03, suggesting a potential upside of 24.41%. Extendicare has a consensus target price of C$8.33, suggesting a potential upside of 8.08%. Given Extendicare's stronger consensus rating and higher probable upside, equities analysts clearly believe dentalcorp is more favorable than Extendicare.
51.3% of dentalcorp shares are owned by institutional investors. Comparatively, 20.2% of Extendicare shares are owned by institutional investors. 0.2% of dentalcorp shares are owned by insiders. Comparatively, 13.9% of Extendicare shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Extendicare has lower revenue, but higher earnings than dentalcorp. dentalcorp is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks.
Summary
Extendicare beats dentalcorp on 10 of the 18 factors compared between the two stocks.
Get Extendicare News Delivered to You Automatically
Sign up to receive the latest news and ratings for EXE and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding EXE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Extendicare Competitors List
Related Companies and Tools
